Johnson & Johnson (NYSE: JNJ) is set to report its first-quarter earnings on Tuesday, April 15th, before the market opens, ...

Q1 2025 Earnings Call Transcript April 15, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, ...

Picking on CSL as an example, much has been made of the extraordinary de-rate in CSL shares over the last five years as the ...

Discover insights from Johnson & Johnson's Q1 2025 earnings call, highlighting 4.2% sales growth, MedTech innovation, and strategies to offset ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Johnson & Johnson raised its 2025 sales outlook and dividend, while Q1 results topped expectations driven by strong cancer drug performance.

While the top- and bottom-line numbers for Johnson & Johnson (JNJ) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics ...

The doctors at Pittsburgh Trauma Medical Center made it through their grueling 15-hour shift — barely.

J&J is projecting a $400m hit due to US tariffs in 2025, but reaffirmed its profit outlook while raising its sales forecast.

There needs to be a passage of time for characters to have absorbed this experience and then have it manifest itself however ...

Shares of Adtalem Global Education are near a record high. The company, our selection for the IBD Stock of the Day, is ...